Faculty ProfilesRuth Dubin
4150 Clement Street
San Francisco, CA 94121
College: Yale University, BA
Medical School: University of California San Francisco, MD
Internal Medicine Residency: University of Texas Southwestern
Nephrology Fellowship: University of California San Francisco
Dr. Dubin is an Assistant Professor in UCSF Nephrology based at the San Francisco VA Medical Center. She has studied the effects of dialysis on cardiac function and post-dialysis fatigue, vascular dysfunction, and physiological mechanisms of elevated cardiac troponin T in persons with end-stage renal disease (ESRD). With funding from a K23 and RO3, Dr. Dubin has built an ESRD cohort of 200 patients to study vascular and cardiac dysfunction in the setting of ESRD, in collaboration with Fresenius Medical Care and DaVita Research. She is a Principal Investigator(PI) in the multi-PI format on the UO1 funded by the NIDDK to study proteomics in chronic kidney disease (CKD), the PI for a study of doxycycline in advanced CKD funded by UCSF, and PI for the Dialysis Readiness, Education and Mentoring (DREAM) project, supported by Cricket Health.
Education and Training
|Location||Degree or Training||Specialty||Date|
|University of California, San Francisco||Clinical Fellowship|
Related Web Sites
Recent Articles (15)
Dubin RF, Deo R, Bansal N, Anderson AH, Yang P, Go AS, Keane M, Townsend R, Porter A, Budoff M, Malik S, He J, Rahman M, Wright J, Cappola T, Kallem R, Roy J, Sha D, Shlipak MG. Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort. Clin J Am Soc Nephrol. 2017 Jan 06; 12(1):60-68.
Dubin RF, Guajardo I, Ayer A, Mills C, Donovan C, Beussink L, Scherzer R, Ganz P, Shah SJ. Associations of Macro- and Microvascular Endothelial Dysfunction With Subclinical Ventricular Dysfunction in End-Stage Renal Disease. Hypertension. 2016 Oct; 68(4):913-20.
Unger ED, Dubin RF, Deo R, Daruwalla V, Friedman JL, Medina C, Beussink L, Freed BH, Shah SJ. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2016 Jan; 18(1):103-12.
Dubin RF, Beatty AL, Teerlink JR, Schiller NB, Alokozai D, Johansen KL. Associations of tissue Doppler imaging with NT-proBNP and hs-TnT: a pilot study in end-stage renal disease. Echocardiography. 2014 Nov; 31(10):1205-12.
Dubin RF, Beatty AL, Teerlink JR, Schiller NB, Bolger AF, Alokozai D, Peralta CA, Johansen KL. Determinants of hemodialysis-induced segmental wall motion abnormalities. Hemodial Int. 2014 Apr; 18(2):396-405.
Dubin RF, Li Y, He J, Jaar BG, Kallem R, Lash JP, Makos G, Rosas SE, Soliman EZ, Townsend RR, Yang W, Go AS, Keane M, Defilippi C, Mishra R, Wolf M, Shlipak MG. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol. 2013 Oct 22; 14:229.
Dubin RF, Teerlink JR, Schiller NB, Alokozai D, Peralta CA, Johansen KL. Association of segmental wall motion abnormalities occurring during hemodialysis with post-dialysis fatigue. Nephrol Dial Transplant. 2013 Oct; 28(10):2580-5.
Dubin R, Li Y, Ix JH, Shlipak MG, Whooley M, Peralta CA. Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study. Am Heart J. 2012 Feb; 163(2):274-9.
Peralta CA, Katz R, Shlipak M, Dubin R, DeBoer I, Jenny N, Fitzpatrick A, Koro C, Kestenbaum B, Ix J, Sarnak M, Cushman M. Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2). Am J Nephrol. 2011; 34(6):512-8.
Dubin R, Cushman M, Folsom AR, Fried LF, Palmas W, Peralta CA, Wassel C, Shlipak MG. Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis. BMC Nephrol. 2011 Jan 26; 12:3.
Dubin R, Shlipak M, Li Y, Ix J, de Boer IH, Jenny N, Peralta CA. Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis. Nephrol Dial Transplant. 2011 Jun; 26(6):1903-8.